Related Experiment Video
Updated: May 13, 2026
08:18
Analysis of Lymph Node Volume by Ultra-High-Frequency Ultrasound Imaging in the Braf/Pten Genetically Engineered Mouse Model of Melanoma
Published on: September 8, 2021
[Progress of anti-tumor study based on BRAF].
Gui-Rui Yan1, Zhi-Jian Xu, He-Yao Wang
1Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Yao Xue Xue Bao = Acta Pharmaceutica Sinica
|March 6, 2013
Summary
BRAF V600E mutations drive tumor growth and are targeted by drugs like Vemurafenib. Understanding resistance mechanisms is key to developing new therapies for BRAF-mutated cancers.
Area of Science:
- Oncology
- Molecular Biology
- Pharmacology
Background:
- BRAF is a key oncogene, with the V600E mutation found in ~8% of human tumors, notably melanoma, colorectal, and thyroid cancers.
- BRAFV600E activates the MEK/ERK pathway, promoting tumor development, invasion, and metastasis, making it a critical therapeutic target.
Purpose of the Study:
- To review the role of BRAFV600E as an anti-tumor target and the evolution of BRAF inhibitors.
- To discuss mechanisms of acquired resistance to BRAF inhibitors.
- To propose strategies for overcoming resistance to BRAF-targeted therapies.
Main Methods:
- Literature review of BRAF oncogene, BRAF inhibitors, and resistance mechanisms.
- Analysis of therapeutic strategies for BRAF-mutated cancers.
- Synthesis of current knowledge on BRAF inhibitor resistance.
Main Results:
- BRAFV600E is a validated therapeutic target, with inhibitors like Vemurafenib showing clinical benefit in melanoma.
- Drug resistance remains a significant limitation to the long-term efficacy of BRAF inhibitors.
- Multiple mechanisms contribute to acquired resistance, necessitating further research.
Conclusions:
- BRAF inhibitors represent a breakthrough in treating BRAFV600E-mutated cancers, but resistance limits their success.
- Understanding resistance pathways is crucial for developing next-generation inhibitors and combination therapies.
- Future strategies should focus on overcoming acquired resistance to improve patient outcomes.
Related Concept Videos
02:07Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...